LEGN Stock Analysis: Buy, Sell, or Hold?
LEGN - Legend Biotech Corporation American Depositary Shares
$21.82
0.56 (2.63%)
â˛
5d:
+7.12%
30d:
-7.27%
90d:
-22.04%
WAIT
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Aug 11, 2026
0d
Get Alerted When LEGN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: LEGN is fairly priced but lacks strong directional signals. At -10.2% expected growth, valuation appears cheap. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: LEGN is fairly priced but lacks strong directional signals. At -10.2% expected growth, valuation appears cheap. Wait for clearer setup or better entry on dips.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$30.97
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$19.23
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: LEGN is currently trading at $21.82, which is considered fair relative to its 30-day fair value range of $19.34 to $23.29. From a valuation perspective, the stock is trading at a discount (Forward PE: 24.7) compared to its historical average (34.1). Remarkably, the market is currently pricing in an annual earnings decline of 10.2% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, LEGN is showing sideways momentum. Immediate support is located at $19.86, while resistance sits at $23.24.
Market Sentiment: LEGN scores 20/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $49.25 (+125.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, LEGN is showing sideways momentum. Immediate support is located at $19.86, while resistance sits at $23.24.
Market Sentiment: LEGN scores 20/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $49.25 (+125.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$19.34 -
$23.29
Company Quality Score
39/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
50.0%
All Signals
- NEUTRAL: Price in fair range
- BEARISH: Weak technical setup (20/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 125.7% below Wall St target ($49.25)
- WARNING: Composite score 39/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$19.34 -
$23.29
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$19.87
Resistance Level
$23.24
Current Trend
Sideways
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
24.68
Wall Street Target
$49.25
(+125.7%)
Revenue Growth (YoY)
51.9%
Profit Margin
-7.2%
Valuation Discount vs History
-10.2% cheaper
PE vs Historical
24.7 vs 34.1
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-10.2%
(market-implied from PE analysis)
1-Year Target
$19.64
(-10%)
2-Year Target
$17.67
(-19%)
3-Year Target
$15.91
(-27%)
3-Yr Target (if PE normalizes)
(PE: 25â34)
$21.98
(+1%)
đĄ
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 24.7 to 34.1
Stabilization Target:
$30.15
(+38.2%)
PE Expansion Potential:
+38.2%
Share & Embed Analysis
Last updated: August 23, 2026 1:10 PM ET
Data refreshes hourly during market hours. Next update: 2:10 PM
Data refreshes hourly during market hours. Next update: 2:10 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is LEGN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Ying Huang
SELL
9936 shares
2026-03-25
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$81 | 58 HOLD |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$55 | 57 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$92 | 54 HOLD |
|
RCKT
Rocket Pharmaceuticals IâĻ |
STRONG BUY
18 analysts |
$9 | 53 HOLD |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$88 | 40 SELL |
